NEW YORK (Reuters) - Two former top executives of drugmaker Schering-Plough Corp were named on Monday as new leaders of privately owned eye-care company Bausch & Lomb.
Former SCHERING (SCH.XE)Plough Chief Executive Officer Fred Hassan will be chairman of Bausch's board, while Brent Saunders, who previously served as president of Schering-Plough's consumer healthcare unit under Hassan, will be Bausch's CEO.
Both appointments are effective immediately, said Bausch, which is majority-owned by Warburg Pincus.
Bausch's Chairman and CEO Gerald Ostrov is retiring and will serve as a consultant to the new leaders.
One of the drug industry's most prominent executives, Hassan left Schering after its acquisition by Merck & Co
(Reporting by Lewis Krauskopf, editing by Dave Zimmerman)
Relacionados
- Los médicos en formación en Andalucía, en la media estatal de ingresos brutos anuales, con 28.209 euros
- Los médicos en formación en Andalucía, en la media estatal de ingresos brutos anuales, con un salario de l28.209 euros
- Economía/Empresas.- Duro Felguera repartirá mañana un dividendo de 0,13 euros brutos por acción
- Los diputados profesionales de las Cortes de Aragón reciben 3.295 euros brutos al mes más complementos
- COMUNICADO: La RAK FTZ consigue un crecimiento de sus ingresos brutos en 2009 de un 11% (1)
